EMA sends more ques­tions to GLP-1 mak­ers over pos­si­ble risk of sui­cide, self-harm

The Eu­ro­pean Med­i­cines Agency’s safe­ty com­mit­tee on Fri­day raised more ques­tions for the mak­ers of GLP-1 weight loss drugs af­ter re­port­ed cas­es of thoughts of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.